Germany's Stratec Biomedical Systems goes public
This article was originally published in Clinica
The German company Stratec Biomedical Systems is to go public in order to raise capital for expansion. It will float 10% of its stock to potential investors and use the proceeds to develop its biotechnology division.
You may also be interested in...
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.